Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ocular adverse effects of Anti-cancer Chemotherapy
Parul Singh, Abhishek Kumar Singh
journal of cancer therapeutics and research (2012) Vol. 1, Iss. 1, pp. 5-5
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Tianmeng Sun, Yu Shrike Zhang, Bo Pang, et al.
Angewandte Chemie International Edition (2014) Vol. 53, Iss. 46, pp. 12320-12364
Closed Access | Times Cited: 1966
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Fakhar ud Din, Waqar Aman, Izhar Ullah, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 7291-7309
Open Access | Times Cited: 1273
Nerolidol: A Sesquiterpene Alcohol with Multi-Faceted Pharmacological and Biological Activities
Weng-Keong Chan, Loh Teng‐Hern Tan, Kok‐Gan Chan, et al.
Molecules (2016) Vol. 21, Iss. 5, pp. 529-529
Open Access | Times Cited: 385
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 100
Ocular toxicities of MEK inhibitors and other targeted therapies
Neda Stjepanovic, Juan P. Velazquez-Martin, Philippe L. Bédard
Annals of Oncology (2016) Vol. 27, Iss. 6, pp. 998-1005
Open Access | Times Cited: 94
Effect of inhibition of the FGFR–MAPK signaling pathway on the development of ocular toxicities
Ruud van der Noll, Suzanne Leijen, Guido H.G. Neuteboom, et al.
Cancer Treatment Reviews (2013) Vol. 39, Iss. 6, pp. 664-672
Closed Access | Times Cited: 98
Maßgeschneiderte Nanopartikel für den Wirkstofftransport in der Krebstherapie
Tianmeng Sun, Yu Shrike Zhang, Bo Pang, et al.
Angewandte Chemie (2014) Vol. 126, Iss. 46, pp. 12520-12568
Closed Access | Times Cited: 80
Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody–Drug Conjugate Mirvetuximab Soravtansine
Ursula A. Matulonis, Michael J. Birrer, David M. O’Malley, et al.
Clinical Cancer Research (2018) Vol. 25, Iss. 6, pp. 1727-1736
Open Access | Times Cited: 61
Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe3O4-PEG-GA) Against Lung, Breast and Colon Cancer Cells
Raihana Rosman, Bullo Saifullah, Sandra Maniam, et al.
Nanomaterials (2018) Vol. 8, Iss. 2, pp. 83-83
Open Access | Times Cited: 60
Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors
Jie Shen, Ming Ma, Hongbo Zhang, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 41, pp. 45838-45849
Open Access | Times Cited: 51
Ocular Toxicity in Metastatic Melanoma Patients Treated With Mitogen-Activated Protein Kinase Kinase Inhibitors: A Case Series
Alfredo Niro, Sabino Strippoli, Giovanni Alessio, et al.
American Journal of Ophthalmology (2015) Vol. 160, Iss. 5, pp. 959-967.e1
Closed Access | Times Cited: 41
Curcumin-loaded, folic acid-functionalized magnetite particles for targeted drug delivery
Melessa Salem, Ying Xia, Alison L. Allan, et al.
RSC Advances (2015) Vol. 5, Iss. 47, pp. 37521-37532
Closed Access | Times Cited: 36
Gelatin-methacryloyl hydrogel based in vitro blood–brain barrier model for studying breast cancer-associated brain metastasis
Robin Augustine, Alap Ali Zahid, Fatima Mraiche, et al.
Pharmaceutical Development and Technology (2021) Vol. 26, Iss. 4, pp. 490-500
Open Access | Times Cited: 26
Posterior Segment Toxicity after Gemcitabine and Docetaxel Chemotherapy
Ali Kord Valeshabad, William F. Mieler, Vikram Setlur, et al.
Optometry and Vision Science (2015) Vol. 92, Iss. 5, pp. e110-e113
Open Access | Times Cited: 23
Systems Perturbation Analysis of a Large-Scale Signal Transduction Model Reveals Potentially Influential Candidates for Cancer Therapeutics
Bhanwar Lal Puniya, Laura Allen, Colleen G. Hochfelder, et al.
Frontiers in Bioengineering and Biotechnology (2016) Vol. 4
Open Access | Times Cited: 22
Changes in the prevalence of comorbidity in the Australian population with cancer, 2007–2014
Huah Shin Ng, Bogda Koczwara, David Roder, et al.
Cancer Epidemiology (2018) Vol. 54, pp. 56-62
Closed Access | Times Cited: 16
Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis
Carlos Alves, Inês Ribeiro, Ana Penedones, et al.
Ophthalmic Research (2016) Vol. 57, Iss. 1, pp. 60-69
Closed Access | Times Cited: 14
Trace Elements in Tears: Comparison of Rural and Urban Populations Using Particle Induced X-ray Emission
Olga Girshevitz, Noa Cohen-Sinai, Alon Zahavi, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1633-1633
Open Access | Times Cited: 8
Dihydropyrimidine Dehydrogenase 85T>C Mutation Is Associated With Ocular Toxicity of 5-Fluorouracil
Yasemin Baskın, Arsalan Amirfallah, Olçun Ümit Ünal, et al.
American Journal of Therapeutics (2013) Vol. 22, Iss. 2, pp. e36-e39
Closed Access | Times Cited: 14
Comparative study between lutein and its liposomal form on cisplatin-induced retinal injury in rabbits
Amal E. Ibrahim, Medhat W. Shafaa, Mahmoud H. Khedr, et al.
Cutaneous and Ocular Toxicology (2019) Vol. 38, Iss. 3, pp. 279-285
Closed Access | Times Cited: 12
Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review
Minas Sakellakis, Nikolaos Spathas, Konstantinos T. Tsaousis, et al.
Cureus (2022)
Open Access | Times Cited: 8
Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment
Yeva Meshkovska, Artem Abramov, Shaheen Mahira, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 651-675
Open Access | Times Cited: 1
Retrobulbar optic neuropathy secondary to isolated sphenoid sinus disease
Vishal Annaji Chafale, Satish A Lahoti, Alak Pandit, et al.
Journal of Neurosciences in Rural Practice (2015) Vol. 6, Iss. 02, pp. 238-240
Open Access | Times Cited: 11
Ocular adverse effects of anti-cancer chemotherapy
Elena Andreea Stoicescu, Raluca Iancu, Alina Popa‐Cherecheanu, et al.
Journal of Medicine and Life (2023) Vol. 16, Iss. 6, pp. 818-821
Open Access | Times Cited: 3
Current Trends in the Clinical Development of Antibody-Drug Conjugates in Oncology
Joseph Dott, Bams Abila, Jens Wuerthner
Pharmaceutical Medicine (2018) Vol. 32, Iss. 4, pp. 259-273
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top